HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Walter Jäger Selected Research

3,3',4,4',5,5'-hexahydroxystilbene

2/2014Effects of hydroxylated resveratrol analogs on oxidative stress and cancer cells death in human acute T cell leukemia cell line: prooxidative potential of hydroxylated resveratrol analogs.
6/20103,3',4,4',5,5'-hexahydroxystilbene impairs melanoma progression in a metastatic mouse model.
8/2008Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Walter Jäger Research Topics

Disease

43Neoplasms (Cancer)
01/2022 - 04/2002
31Breast Neoplasms (Breast Cancer)
12/2020 - 04/2005
8Neoplasm Metastasis (Metastasis)
04/2019 - 05/2011
6Carcinoma (Carcinomatosis)
05/2018 - 10/2002
5Infections
10/2021 - 04/2013
4Critical Illness (Critically Ill)
04/2020 - 04/2011
4Colonic Neoplasms (Colon Cancer)
01/2020 - 07/2015
3Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 07/2015
3Ovarian Neoplasms (Ovarian Cancer)
01/2020 - 09/2011
3Melanoma (Melanoma, Malignant)
03/2015 - 06/2010
2Endometrial Neoplasms (Endometrial Cancer)
04/2021 - 01/2021
2Lung Neoplasms (Lung Cancer)
01/2020 - 01/2017
2Disease Progression
04/2019 - 10/2002
2Renal Insufficiency (Renal Failure)
09/2017 - 04/2011
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2015 - 01/2015
2Inflammation (Inflammations)
07/2015 - 01/2011
2Carcinogenesis
11/2014 - 03/2012
2Leukemia
02/2014 - 08/2002
2Body Weight (Weight, Body)
01/2014 - 03/2012
2Abscess
10/2012 - 01/2012
2Prostatic Neoplasms (Prostate Cancer)
10/2002 - 04/2002
1Central Nervous System Neoplasms
01/2022
1Tardive Dyskinesia
01/2021
1Liver Failure
04/2020
1Acute-On-Chronic Liver Failure
04/2020
1Avian Reticuloendotheliosis
01/2020
1Anorexia
04/2019
1Nausea
04/2019
1Neuralgia (Stump Neuralgia)
04/2019

Drug/Important Bio-Agent (IBA)

15Estrogens (Estrogen)FDA Link
04/2021 - 12/2010
15Pharmaceutical PreparationsIBA
01/2021 - 04/2002
11ResveratrolIBA
01/2019 - 09/2009
10Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2004
10Hormones (Hormone)IBA
12/2020 - 04/2002
9Peptides (Polypeptides)IBA
11/2020 - 05/2011
8AnionsIBA
11/2020 - 05/2011
6Anti-Bacterial Agents (Antibiotics)IBA
10/2021 - 01/2012
6SteroidsIBA
12/2020 - 01/2013
6Messenger RNA (mRNA)IBA
04/2019 - 01/2004
5Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2018 - 04/2002
4Estrogen Receptor alphaIBA
12/2020 - 01/2017
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2020 - 08/2013
4EnzymesIBA
11/2014 - 08/2002
3AndrogensIBA
12/2020 - 10/2002
3AcidsIBA
01/2020 - 10/2013
3Estrogen ReceptorsIBA
04/2019 - 09/2012
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2019 - 01/2011
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2016 - 04/2002
33,3',4,4',5,5'-hexahydroxystilbeneIBA
02/2014 - 08/2008
3Antiviral Agents (Antivirals)IBA
01/2014 - 10/2002
3MelatoninIBA
03/2012 - 01/2008
2Meropenem (Merrem)FDA LinkGeneric
10/2021 - 04/2020
2SulfatasesIBA
01/2021 - 01/2013
2ProstaglandinsIBA
11/2020 - 10/2002
2Small Interfering RNA (siRNA)IBA
01/2020 - 11/2012
2Biological ProductsIBA
01/2020 - 01/2013
2GTP-Binding Proteins (G-Protein)IBA
04/2019 - 01/2008
2CurcuminIBA
04/2019 - 08/2017
2Adenosine Triphosphate (ATP)IBA
01/2019 - 08/2013
2Tyrosine Kinase InhibitorsIBA
01/2019 - 01/2019
2PolyphenolsIBA
01/2019 - 02/2014
2Arachidonic Acid (Vitamin F)IBA
07/2018 - 01/2016
2FlavonoidsIBA
01/2018 - 01/2018
2EstroneFDA Link
01/2018 - 01/2013
2Biomarkers (Surrogate Marker)IBA
05/2017 - 01/2015
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
11/2016 - 04/2002
2Anaplastic Lymphoma KinaseIBA
08/2015 - 01/2015
2ParaffinIBA
01/2015 - 01/2004
2Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
11/2014 - 03/2012
2Sulfates (Sulfates, Inorganic)IBA
09/2014 - 01/2013
2AntioxidantsIBA
03/2012 - 08/2008
2Antineoplastic Agents (Antineoplastics)IBA
05/2011 - 04/2002
2Melatonin Receptors (Melatonin Receptor)IBA
04/2011 - 01/2008
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2011 - 01/2008
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1Metoclopramide (Reglan)FDA LinkGeneric
01/2021
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
01/2021
1AntiemeticsIBA
01/2021
1acteinIBA
12/2020
1black cohosh root extractIBA
12/2020
1Organic Anion TransportersIBA
11/2020
1Fluorescein (Funduscein)FDA LinkGeneric
11/2020
1Bile Acids and Salts (Bile Acids)IBA
11/2020
1PlatinumIBA
01/2020
1defactinibIBA
01/2020
1ponatinibIBA
01/2020
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2020
1LipidsIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1TamoxifenFDA LinkGeneric
04/2019
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2019
1Selective Estrogen Receptor Modulators (SERM)IBA
04/2019
1Dronabinol (THC)FDA LinkGeneric
04/2019
1CannabinoidsIBA
04/2019

Therapy/Procedure

17Therapeutics
04/2019 - 04/2002
5Drug Therapy (Chemotherapy)
01/2020 - 08/2002
3Continuous Renal Replacement Therapy
04/2020 - 01/2014
1Renal Dialysis (Hemodialysis)
04/2020
1Cytoreduction Surgical Procedures
01/2020
1Palliative Care (Palliative Therapy)
04/2019